Dermapharm Holding SE (LTS:0A5J) Other Net Income (Loss) : €0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Dermapharm Holding SE Other Net Income (Loss)?

Dermapharm Holding SE's Other Net Income (Loss) for the three months ended in Mar. 2025 was €0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was €0 Mil.

Dermapharm Holding SE's quarterly Other Net Income (Loss) declined from Sep. 2024 (€0 Mil) to Dec. 2024 (€-0 Mil) but then increased from Dec. 2024 (€-0 Mil) to Mar. 2025 (€0 Mil).

Dermapharm Holding SE's annual Other Net Income (Loss) declined from Dec. 2022 (€0 Mil) to Dec. 2023 (€-0 Mil) but then increased from Dec. 2023 (€-0 Mil) to Dec. 2024 (€0 Mil).

Dermapharm Holding SE Other Net Income (Loss) Historical Data

The historical data trend for Dermapharm Holding SE's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Other Net Income (Loss) Chart

Dermapharm Holding SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Dermapharm Holding SE Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Dermapharm Holding SE Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Dermapharm Holding SE Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (LTS:0A5J) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

DMPHF:USA DMPd:UK DMP:Germany

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.com

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Dermapharm Holding SE Headlines

No Headlines